Kidney or liver conditions might affect how you metabolize the medication, potentially requiring dose adjustments or extended time at lower doses
This is not optional during aggressive weight loss
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences
Consistent with the effects of GCGR in increasing lipolysis and thermogenesis besides elevating blood glucose levels, preclinical studies have found that peptide 20 improved energy metabolism and hepatic lipid handling without exacerbating preexisting hyperglycemia 22
Zhu H, Wang X, Meng X, Kong Y, Li Y, Yang C, et al
While this lean mass loss is proportional to the total weight loss and generally considered acceptable, it underscores the importance of resistance training and adequate protein intake during treatment